Joerg Herrmann

17.1k total citations · 2 hit papers
202 papers, 8.5k citations indexed

About

Joerg Herrmann is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Joerg Herrmann has authored 202 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Cardiology and Cardiovascular Medicine, 77 papers in Radiology, Nuclear Medicine and Imaging and 57 papers in Oncology. Recurrent topics in Joerg Herrmann's work include Chemotherapy-induced cardiotoxicity and mitigation (84 papers), Cardiac Imaging and Diagnostics (70 papers) and Cancer Treatment and Pharmacology (29 papers). Joerg Herrmann is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (84 papers), Cardiac Imaging and Diagnostics (70 papers) and Cancer Treatment and Pharmacology (29 papers). Joerg Herrmann collaborates with scholars based in United States, Germany and United Kingdom. Joerg Herrmann's co-authors include Amir Lerman, Rhian M. Touyz, Abhiram Prasad, Sandra M. Herrmann, Lilach O. Lerman, Feilong Wang, David R. Holmes, Hector R. Villarraga, Nicole P. Sandhu and Cezar Iliescu and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.

In The Last Decade

Joerg Herrmann

189 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia

2020 436 citations Joerg Herrmann profile →
5-fluorouracil and cardiotoxicity: a review

2018 293 citations Joerg Herrmann, Amir Lerman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joerg Herrmann United States	50	4.6k	2.0k	1.9k	1.8k	1.6k	202	8.5k
Bonnie Ky United States	51	6.8k 1.5×	1.8k 0.9×	2.8k 1.4×	956 0.5×	1.2k 0.8×	215	9.9k
Marielle Scherrer‐Crosbie United States	50	5.3k 1.1×	1.6k 0.8×	1.5k 0.8×	1.1k 0.6×	1.8k 1.1×	169	8.7k
Tomas G. Neilan United States	50	5.2k 1.1×	2.0k 1.0×	2.4k 1.3×	687 0.4×	752 0.5×	216	8.2k
Petr Jarolı́m United States	53	4.1k 0.9×	896 0.5×	631 0.3×	1.6k 0.8×	1.9k 1.2×	224	9.2k
Yaling Han China	37	3.1k 0.7×	688 0.4×	915 0.5×	2.5k 1.4×	2.0k 1.3×	511	7.7k
Jourik A. Gietema Netherlands	56	2.1k 0.4×	1.5k 0.8×	3.5k 1.8×	2.4k 1.3×	3.0k 1.9×	252	10.1k
Anju Nohria United States	43	4.6k 1.0×	1.0k 0.5×	1.7k 0.9×	913 0.5×	600 0.4×	149	6.8k
Daniel J. Lenihan United States	45	6.8k 1.5×	1.8k 0.9×	3.9k 2.0×	720 0.4×	1.6k 1.0×	232	9.7k
Javid J. Moslehi United States	68	6.4k 1.4×	1.5k 0.8×	6.6k 3.4×	1.2k 0.6×	3.7k 2.4×	211	16.0k
Kiyoshi Yoshida Japan	49	5.6k 1.2×	3.2k 1.6×	644 0.3×	3.8k 2.1×	927 0.6×	327	9.4k

Countries citing papers authored by Joerg Herrmann

Since Specialization

Citations

This map shows the geographic impact of Joerg Herrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joerg Herrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joerg Herrmann more than expected).

Fields of papers citing papers by Joerg Herrmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joerg Herrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joerg Herrmann. The network helps show where Joerg Herrmann may publish in the future.

Co-authorship network of co-authors of Joerg Herrmann

This figure shows the co-authorship network connecting the top 25 collaborators of Joerg Herrmann. A scholar is included among the top collaborators of Joerg Herrmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joerg Herrmann. Joerg Herrmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Donisan, Teodora, Dinu Valentin Balanescu, Ian C Chang, et al.. (2025). Radionuclide imaging in cardio-oncology: A clinical decision-making tool. Progress in Cardiovascular Diseases. 93. 66–74.

Herrmann, Joerg & Alexander R Lyon. (2025). Immune checkpoint inhibitor myocarditis—a score to tell you more. European Heart Journal. 47(9). 1063–1065.

Chen, Miao, Song Zhang, Zhibing Luo, et al.. (2024). UK5099 Inhibits the NLRP3 Inflammasome Independently of its Long‐Established Target Mitochondrial Pyruvate Carrier. Advanced Science. 11(33). e2307224–e2307224. 8 indexed citations

Abbasi, Muhannad, Yi Lin, Jonas Paludo, et al.. (2024). Baseline echocardiographic variables as predictors of hemodynamically significant cytokine release syndrome in adults treated with CD19 CAR T-cell therapy for hematological malignancies. Cardio-Oncology. 10(1). 91–91. 2 indexed citations

Peclat, Thais, Guillermo Agorrody, Sonu Kashyap, et al.. (2024). Ecto-CD38-NADase inhibition modulates cardiac metabolism and protects mice against doxorubicin-induced cardiotoxicity. Cardiovascular Research. 120(3). 286–300. 5 indexed citations

Kurmann, Reto, Edward El‐Am, Ali Ahmad, et al.. (2023). Cardiac Masses Discovered by Echocardiogram; What to Do Next?. Structural Heart. 7(4). 100154–100154. 7 indexed citations

Vierkant, Robert A., Janet E. Olson, Joerg Herrmann, et al.. (2023). Changes in amount and intensity of physical activity over time in breast cancer survivors. JNCI Cancer Spectrum. 7(5). 7 indexed citations

Jacobs, J., Yu‐Ling Yu, Caroline Weltens, et al.. (2023). Mortality and Major Adverse Cardiac Events in Patients With Breast Cancer Receiving Radiotherapy: The First Decade. Journal of the American Heart Association. 12(8). e027855–e027855. 13 indexed citations

Herrmann, Joerg, Teresa López‐Fernández, & Alexander R. Lyon. (2023). The year in cardiovascular medicine 2022: the top 10 papers in cardio-oncology. European Heart Journal. 44(5). 348–350. 1 indexed citations

10.

Zhang, Song, Guosheng Wang, Jiaxing Sun, et al.. (2023). Mitochondrial pyruvate carrier-mediated metabolism is dispensable for the classical activation of macrophages. Nature Metabolism. 5(5). 804–820. 23 indexed citations

11.

Ng, Choon Ta, Li Ling Tan, Il Suk Sohn, et al.. (2022). Advancing Cardio-Oncology in Asia. Korean Circulation Journal. 53(2). 69–69. 4 indexed citations

12.

Vierkant, Robert A., Janet E. Olson, Joerg Herrmann, et al.. (2022). Factors Associated With Physical Activity Levels in Patients With Breast Cancer. The Oncologist. 27(10). e811–e814. 4 indexed citations

13.

Herrmann, Joerg, Teresa López‐Fernández, & Alexander R. Lyon. (2021). The year in cardiovascular medicine 2021: cardio-oncology. European Heart Journal. 8 indexed citations

14.

Boddicker, Nicholas, Melissa C. Larson, Alessia Castellino, et al.. (2021). Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era. American Journal of Hematology. 96(8). 979–988. 10 indexed citations

15.

Wang, Yong, Xiaoping Wang, Qi Qiu, et al.. (2021). atg7 -Based Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity. Circulation Research. 129(8). e166–e182. 64 indexed citations

16.

Vaughan, Lisa E., Collin M. Costello, Charat Thongprayoon, et al.. (2020). Clinical outcomes of solid organ transplant recipients with metastatic cancers who are treated with immune checkpoint inhibitors: A single‐center analysis. Cancer. 126(21). 4780–4787. 27 indexed citations

17.

Yang, Eric H., Joerg Herrmann, Cezar Iliescu, et al.. (2019). Applications of Cardiac Computed Tomography in the Cardio-Oncology Population. Current Treatment Options in Oncology. 20(6). 47–47. 12 indexed citations

18.

Taparra, Kekoa, Scott C. Lester, Phillip M. Young, et al.. (2018). A Comparison of Proton and X-ray Therapy for Coronary Artery Sparing Using ECG-gated CT with Coronary Angiography for Mediastinal Lymphoma. International Journal of Radiation Oncology*Biology*Physics. 102(3). S87–S88. 1 indexed citations

19.

Herrmann, Joerg, Bernard J. Gersh, Judith Z. Goldfinger, et al.. (2014). Body Mass Index and Acute and Long-Term Outcomes After Acute Myocardial Infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial). The American Journal of Cardiology. 114(1). 9–16. 33 indexed citations

20.

Hildebrandt, Heike, Mario Gössl, Dallit Mannheim, et al.. (2007). Differential distribution of vasa vasorum in different vascular beds in humans. Atherosclerosis. 199(1). 47–54. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact